BIOMAT Database Logo BIOMAT Database Logo

Lithium antidepressant augmentation in TCA-refractory depression in adolescents. 1988

N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium augmentation in refractory depression.
January 1988, Psychiatric developments,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium augmentation in venlafaxine-refractory depression.
April 2001, Journal of clinical psychopharmacology,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression.
March 1990, Journal of affective disorders,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
December 1983, Archives of general psychiatry,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium augmentation in treatment-refractory unipolar depression.
May 2003, The British journal of psychiatry : the journal of mental science,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
[Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
December 1991, Harefuah,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium augmentation therapy in refractory depression-update 2002.
June 2003, European archives of psychiatry and clinical neuroscience,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium augmentation of antidepressants in treatment-refractory depression.
January 1998, The Journal of clinical psychiatry,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Lithium carbonate augmentation of desipramine in refractory depression.
October 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
N D Ryan, and V Meyer, and S Dachille, and D Mazzie, and J Puig-Antich
Serotonergic function during lithium augmentation of refractory depression.
January 1992, Psychopharmacology,
Copied contents to your clipboard!